Pfizer Ponders Divesting Non-Core Consumer Brands In Europe
This article was originally published in The Tan Sheet
Executive Summary
Pfizer's decision to sell many of its smaller consumer brands in Europe could portend a similar scenario in the U.S
You may also be interested in...
Pfizer’s Zyrtec Remains Strong As Rx Antihistamine Market Weakens
The many loratadine products now available in the OTC market have not been able to undercut sales for Pfizer's Zyrtec (cetirizine), according to the company
Pfizer’s Zyrtec Remains Strong As Rx Antihistamine Market Weakens
The many loratadine products now available in the OTC market have not been able to undercut sales for Pfizer's Zyrtec (cetirizine), according to the company
Pfizer’s Zyrtec Remains Strong As Rx Antihistamine Market Weakens
The many loratadine products now available in the OTC market have not been able to undercut sales for Pfizer's Zyrtec (cetirizine), according to the company